Kirin / Blackmores deal – Exclusive analysis: Japan g

Kirin’s is expected to double down on Blackmores’ R&D capabilities and new product development in the wake of its $1.2bn deal, according to exclusive insights from the Japanese giant and industry experts.

Related Keywords

Indonesia , Malaysia , United Kingdom , China , Japan , Thailand , Carlton , Tasmania , Australia , Hong Kong , Brazil , Aussie , Japanese , Australian , Glenn Cochrane , George Tambassis , Hisaaki Kato , Marcus Blackmore , Takeshi Minakata , Japan Consumer Affairs Agency , Thorne Research , Clink Inc , Happiness Grouphh Group , Kirin Holdings Corporate Communications Department , Health Science Business Division , Suntory , Health Science Division , Mitsui , Reuters , Strategy Of The Health Science Domain , Function Claims , South East Asian , South East Asia , Health Science , Pwc Consulting , Russell Roll , Smooth Link Inc , Remedy Health , Otsuka Pharmaceutical Owned Pharmavite , Otsuka Pharmaceutical , Care Laboratories , Happiness Group , Ingredients , Pirin , Blackmores ,